Navigation Links
Nephrologists summarize new renal research during public policy news briefing at Renal Week

Renal experts will summarize important new research on the topics of cardiovascular risk in chronic kidney disease, consequences of acute kidney injury, racial and ethnic disparities of kidney disease, and anemia management in kidney disease patients, being presented during the American Society of Nephrology's 40th Annual Meeting and Scientific Exposition in San Francisco at a policy-centered news briefing on Saturday, November 3.

We hope that by highlighting significant research that could directly impact public health in America, we can ultimately improve health outcomes, said Jonathan Himmelfarb, MD of Maine Medical Center, Chair of ASNs Public Policy Board and moderator of the briefing.

Following a brief introduction by Dr. Himmelfarb, Mark J. Sarnak, MD, FASN of Tufts-New England Medical Center will discuss the link between chronic kidney disease (CKD) and cardiovascular disease (CVD) in his briefing presentation, The CKD - CVD Connection. Chi-yuan Hsu, MD, MS of University of California, San Francisco will address The Consequences of Acute Kidney Injury. The third topic, Race, Ethnicity in Outcomes of Patients with Kidney Disease (Health Disparities) will be presented by Neil R. Powe, MD, MPH, MBA, FASN of the Johns Hopkins University School of Medicine. Lynda A. Szczech, MD, MSCE, FASN of Duke University Medical Center will conclude the briefing with a discussion on The Treatment of Anemia in Kidney Disease.

The Public Policy News Briefing will take place on Saturday, November 3, 2007 from 12:15 pm to 1:15 pm in Room 236 of the Moscone Center South in San Francisco.


Contact: Shari Leventhal
American Society of Nephrology

Page: 1

Related medicine news :

1. Nephrologists Reassess Disaster Response Strategies
2. Renal problem alleviated
3. Increase in renal problems
4. Effect of drug on Renal Cancer
5. Renal problem increased
6. Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients
7. Acute Toxicity Of Nano-Scale Zinc Powder: Severe Renal Damage And Anemia
8. A Novel Method Of Detection Of High Nuclear Grade Localized Renal Cell Carcinoma
9. Negative Impact Of Hepatitis C Infection In Renal Transplant Recipients
10. Clinical Renal Trails Do Not Have Sufficient Women Participants
11. Adrenal Suppression not predicted by inhaled corticosteroids
Post Your Comments:
(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A ... 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the ... history as home to some of the world’s leading providers of cereal and other ...
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is ... a fitness app. The fitness app plans to fix the two major problems leading the ... one size fits all type program , They don’t eliminate all the reasons ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
Breaking Medicine Technology: